ERITROCITOSIS TRATAMIENTO PDF

ERITROCITOSIS PATOLÓGICA DE ALTURA: Caracterización biológica, diagnóstico y tratamiento. HIGH ALTITUDE PATHOLOGICAL ERYTHROCYTOSIS. Diagnóstico y tratamiento | 23 DIC Eritrocitosis. Actualización de los métodos diagnósticos y el manejo de los pacientes con eritrocitosis. 3. original research. DOI: Secondary erythrocytosis due to hypoxemia as prognosis. in exacerbated chronic .

Author: Doule Yokinos
Country: Republic of Macedonia
Language: English (Spanish)
Genre: Sex
Published (Last): 24 September 2015
Pages: 67
PDF File Size: 12.89 Mb
ePub File Size: 11.12 Mb
ISBN: 558-9-81992-209-5
Downloads: 55199
Price: Free* [*Free Regsitration Required]
Uploader: Gagore

INADEQUATE TREATMENT OF EXCESSIVE ERYTHROCYTOSIS

History of heart failure. Multivariate analysis of prognostic factors for the composite outcome. Paraclinical variables at admission. None of these tratamientl presented any of the outcomes assessed at 30 days.

Eritrocitosis – Artículos – IntraMed

Leuk Lymphoma ; published online 29 Jul. This study aimed to determine whether there is a relationship between the red cell prognostic parameters and adverse outcomes at 30 days in patients admitted under the diagnostic impression of an exacerbated chronic lung disease and secondary hypoxemia. Almost half of patients had a history of smoking and it was two times higher in men compared to women.

Polycythaemia due to hypoxaemia: This is why the diagnosis reported by the patient and relatives was chosen, making it difficult to determine which patients actually had a chronic lung disease and which type.

On the other hand, the presence of the exacerbation did not differ according to the Anthonisen criteria, but did show a trend to greater affectation of oxygenation and hypercapnia in the presence of higher hematocrit levels. Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: Regarding the outcomes, there was a predilection to higher length hospital stay in the presence of lower levels of hematocrit.

Efficacy and safety of low-dose aspirin in polycythemia vera. Ann Intern Med ; The results showed that exacerbations of chronic lung diseases afflicted, with very little difference in frequency, both men and women and appeared at similar ages, without any difference in the severity of the disease, although comorbidities are more often associated with women. Type chronic lung disease. Effects on pulmonary hemodynamics, gas exchange, and exercise capacity. In addition, the distribution of variables was stratified by sex and hematocrit value, which was categorized into three groups according to the 25th and 75th percentiles of the distribution.

  EVOLUTION HANDBOOK VANCE FERRELL PDF

The frequency of anemia was 7. Treatment of polycythemia vera with hydroxyurea and pipobroman: The collection of the sample was interrupted between June and August due to issues in the attention of users in the institution, which affected the admission of patients. The potential impact of anaemia of chronic disease in COPD. To define the entry of each individual to the study, the patient or caregiver was asked to sign an informed consent during the initial interview for authorization to collect data, accessing medical records, follow-up at 30 days and processing the information obtained.

Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. Follow-up was completed for Patients.

The prognostic value of this variable in the exacerbation has not been evaluated to date. At each step, the fulfillment of the criteria for inclusion and exclusion was verified.

Diffuse interstitial lung disease. There are several observations that have found a worse prognosis of mortality and need for hospitalization in patients with lower red cell mass compared to those with higher values 9,10, Predictors of outcomes in COPD exacerbation cases presenting to the emergency department.

Length of hospital stay days.

Determining egitrocitosis virtual implications of red cell parameters in patients with pulmonary exacerbations could help defining the particular use of measures such as phlebotomy or red blood cell transfusion. Study assessments After checking the study entry criteria and obtaining the authorization of the patients or caregiver for inclusion, we proceeded to collect information through a survey to patients during their hospital stay.

  C CODING STANDARDS BY HERB SUTTER AND ANDREI ALEXANDRESCU PDF

Erythrocyte parameters before and after performing phlebotomy in the recorded cases. Depending on the outcome, the abnormally distributed variables were reported by their median and interquartile range, while those presenting normal distribution were reported by their mean and standard deviation.

Variables were described using an additional categorization by hematocrit levels and an adjustment in a multivariate model through logistic regression.

Revista de la Facultad de Medicina

Chronic eritfocitosis pulmonary disease. Use of short-acting anticholinergic. Use of long-acting anticholinergic. Erythrocyte parameters showed an overall predilection of being within normal values, with a median of By contrast, other tratamienot factors found to be related with exacerbations in other studies, such as age, use of home oxygen, the presence of signs of respiratory distress at admission, the number of Anthonisen criteria present and blood gases, could not be validated in this cohort 2,5,22,23, Discussion This study attempted to establish the relationship between red blood cell parameters and the development of adverse outcomes at 30 days in patients with exacerbated chronic lung disease.

Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: Diabetes mellitus type 2. It differentiates the medians of independent samples in the analysis of quantitative variables that do not follow a normal distribution with the eritrociotsis variable.